PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsCefotaxime
Cefotaxime
Claforan (cefotaxime) is a small molecule pharmaceutical. Cefotaxime was first approved as Claforan on 1982-01-01. It is used to treat acinetobacter infections, bacterial infections, bacterial meningitis, bacterial pneumonia, and bacterial skin diseases amongst others in the USA.
Download report
Favorite
Searched
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
musculoskeletal diseasesD009140
digestive system diseasesD004066
respiratory tract diseasesD012140
nervous system diseasesD009422
urogenital diseasesD000091642
skin and connective tissue diseasesD017437
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Cefotaxime sodium
Tradename
Company
Number
Date
Products
CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINERB. Braun MedicalN-050792 DISCN2004-07-29
1 products
CEFOTAXIME AND DEXTROSE 3.9% IN PLASTIC CONTAINERB. Braun MedicalN-050792 DISCN2004-07-29
1 products
CLAFORANValidus PharmaceuticalsN-050547 DISCN1982-01-01
4 products, RLD
CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERValidus PharmaceuticalsN-050596 DISCN1985-05-20
1 products
CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINERValidus PharmaceuticalsN-050596 DISCN1985-05-20
1 products
CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERValidus PharmaceuticalsN-050596 DISCN1985-05-20
1 products
CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINERValidus PharmaceuticalsN-050596 DISCN1985-05-20
1 products
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
cefotaximeunapproved drug for use in drug shortage2024-12-12
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
J: Antiinfectives for systemic use
J01: Antibacterials for systemic use
J01D: Other beta-lactam antibacterials in atc
J01DD: Third-generation cephalosporins
J01DD01: Cefotaxime
J01DD51: Cefotaxime and beta-lactamase inhibitor
HCPCS
Code
Description
J0698
Injection, cefotaxime sodium, per gm
Clinical
Clinical Trials
72 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
InfectionsD007239EFO_000054414813
Communicable diseasesD00314113711
SepsisD018805EFO_0001420A41.93148
PneumoniaD011014EFO_0003106J181247
PeritonitisD010538EFO_0008588K652136
Critical illnessD0166381135
Ventilator-associated pneumoniaD053717EFO_1001865J95.8511214
OsteomyelitisD010019EFO_0003102M861113
Urinary tract infectionsD014552EFO_0003103N39.0213
ToxemiaD0141151113
Show 9 more
Indications Phases 3
Indications Phases 2
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Bacterial infectionsD001424A49123
Brain injuriesD001930S06.911
Focus groupsD01714411
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Respiratory tract infectionsD012141J06.966
Pregnancy complicationsD01124811
Infectious pregnancy complicationsD01125111
Neonatal sepsisD00007107411
Continuous renal replacement therapyD00007966411
Penicillin resistanceD01040311
Acute kidney injuryD058186N1711
Respiratory distress syndromeD012128EFO_1000637J8011
Newborn respiratory distress syndromeD012127P2211
FistulaD00540211
Show 31 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameCefotaxime
INNcefotaxime
Description
(6R,7R)-3-(acetyloxymethyl)-7-[[2-(2-amino-4-thiazolyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid is a cephalosporin.
Classification
Small molecule
Drug classcephalosporins
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS[C@H]12)c1csc(N)n1
Identifiers
PDB
CAS-ID63527-52-6
RxCUI
ChEMBL IDCHEMBL1730
ChEBI ID204928
PubChem CID5479527
DrugBankDB00493
UNII IDN2GI8B1GK7 (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 34,299 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
3,798 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use